News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
702,057 Results
Type
Article (40326)
Company Profile (297)
Press Release (661434)
Section
Business (206940)
Career Advice (2069)
Deals (35860)
Drug Delivery (98)
Drug Development (82281)
Employer Resources (173)
FDA (16205)
Job Trends (15142)
News (349787)
Policy (32800)
Tag
Academia (2555)
Alliances (50115)
Alzheimer's disease (1338)
Approvals (16189)
Artificial intelligence (203)
Bankruptcy (360)
Best Places to Work (11757)
Biotechnology (212)
Breast cancer (226)
Cancer (1724)
Cardiovascular disease (132)
Career advice (1720)
CAR-T (122)
Cell therapy (359)
Clinical research (66291)
Collaboration (672)
Compensation (376)
COVID-19 (2586)
C-suite (164)
Data (1641)
Diabetes (211)
Diagnostics (6302)
Earnings (86465)
Employer resources (150)
Events (113278)
Executive appointments (574)
FDA (17112)
Funding (605)
Gene therapy (250)
GLP-1 (675)
Government (4398)
Healthcare (18851)
Infectious disease (2697)
Inflammatory bowel disease (122)
Interviews (327)
IPO (16697)
Job creations (3834)
Job search strategy (1467)
Layoffs (451)
Legal (7935)
Lung cancer (255)
Manufacturing (240)
Medical device (13278)
Medtech (13283)
Mergers & acquisitions (19541)
Metabolic disorders (559)
Neuroscience (1749)
NextGen: Class of 2025 (6568)
Non-profit (4494)
Northern California (2099)
Obesity (311)
Opinion (210)
Patents (162)
People (57682)
Phase I (20680)
Phase II (29265)
Phase III (21669)
Pipeline (716)
Postmarket research (2572)
Preclinical (8723)
Radiopharmaceuticals (251)
Rare diseases (322)
Real estate (6021)
Regulatory (22174)
Research institute (2334)
Resumes & cover letters (354)
Southern California (1802)
Startups (3649)
United States (18667)
Vaccines (624)
Weight loss (217)
Date
Last 7 days (604)
Last 30 days (2484)
Last 365 days (34856)
2025 (4489)
2024 (35729)
2023 (40661)
2022 (51785)
2021 (56339)
2020 (54535)
2019 (46980)
2018 (35385)
2017 (32635)
2016 (32060)
2015 (38110)
2014 (32005)
2013 (26893)
2012 (29013)
2011 (29670)
2010 (27706)
Location
Africa (739)
Arizona (213)
Asia (38799)
Australia (6272)
California (4795)
Canada (1722)
China (405)
Colorado (219)
Connecticut (233)
Europe (83635)
Florida (697)
Georgia (165)
Illinois (458)
Indiana (261)
Maryland (753)
Massachusetts (3658)
Michigan (198)
Minnesota (336)
New Jersey (1363)
New York (1366)
North Carolina (885)
Northern California (2099)
Ohio (174)
Pennsylvania (1103)
South America (1118)
Southern California (1802)
Texas (709)
Utah (144)
Washington State (476)
702,057 Results for "akeso biopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Akeso Received Payment for the Development Collaboration on Tagitanlimab
January 22, 2025
·
1 min read
Press Releases
Akeso Biopharma to Attend Jefferies London Healthcare Conference and Morgan Stanley 23rd Asia Pacific Summit
November 18, 2024
·
5 min read
Press Releases
Akeso Announced Enrollment of First Patient in Phase 3 Trial of Cadonilimab for Consolidation Therapy After Concurrent or Sequential Chemoradiotherapy in NSCLC
February 12, 2025
·
3 min read
Press Releases
Akeso Enrolled First Patient in The Phase III Clinical Trial of Ivonescimab in Combination with Chemotherapy for First-Line Treatment of Triple-Negative Breast Cancer
February 21, 2025
·
4 min read
Press Releases
Akeso’s Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA
January 27, 2025
·
6 min read
Press Releases
Akeso Announces IND Acceptance for AK139, a Bispecific Antibody Targeting IL-4Rα and ST2 for Respiratory and Skin Diseases
February 14, 2025
·
3 min read
Press Releases
Akeso to Share Global Strategy for New Drug Development at the 43rd J.P. Morgan Healthcare Conference
January 7, 2025
·
2 min read
Press Releases
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
February 20, 2025
·
5 min read
Bankruptcy
Biopharma Bankruptcies Still At Peak, With Little Relief in Sight
2023 marked the most bankruptcies in biopharma in more than a decade, with 14 companies filing for Chapter 11 protection. The number remained high in 2024.
February 19, 2025
·
5 min read
·
Annalee Armstrong
Press Releases
Akeso Announces the Completion of Patient Enrollment in the Phase III Clinical Trial (HARMONi-6) Comparing Ivonescimab and Tislelizumab for First-Line Treatment of Sq-NSCLC
February 5, 2025
·
3 min read
1 of 70,206
Next
